Financhill
Sell
37

RMTI Quote, Financials, Valuation and Earnings

Last price:
$2.07
Seasonality move :
14.82%
Day range:
$1.98 - $2.12
52-week range:
$1.16 - $5.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.64x
P/B ratio:
2.31x
Volume:
479.7K
Avg. volume:
1.1M
1-year change:
16.2%
Market cap:
$67.2M
Revenue:
$83.6M
EPS (TTM):
-$0.06

Earnings Data

Next earnings date for RMTI
Mar 21
2025
Most recent earnings per share
$0.04
Beat by $0.05
(Nov 12/2024)
Consensus Estimate
-$0.01
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RMTI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/21/2025 Q4 $23.7M -- -- $0.01 --
11/12/2024 Q3 $26.5M $28.3M $0.04 -$0.01 $0.05
08/08/2024 Q2 $22.9M $25.8M $0.01 -$0.05 $0.06
05/14/2024 Q1 $21.7M $22.7M -$0.06 -$0.07 $0.01
03/21/2024 Q4 $22.6M $22.1M -$0.05 -- --
11/14/2023 Q3 -- -- -$0.07 -$0.09 $0.02
08/14/2023 Q2 -- -- -$0.18 -$0.12 -$0.06
05/15/2023 Q1 -- -- -$0.10 -$0.28 $0.18
03/30/2023 Q4 -- -- -$0.20 -$0.39 $0.19
11/15/2022 Q3 -- -- -$0.23 -- --
06/30/2022 Q2 -- -- -$0.43 -- --
05/17/2022 Q1 -- -- -$0.84 -- --
03/30/2022 Q4 -- -- -$1.04 -- --
11/15/2021 Q3 -- -- -$0.89 -- --
08/16/2021 Q2 -- -- -$0.99 -- --
05/17/2021 Q1 -- -- -$0.91 -- --
03/31/2021 Q4 -- -- -$0.99 -- --
11/09/2020 Q3 -- -- -$1.10 -- --
08/10/2020 Q2 -- -- -$1.10 -- --
05/11/2020 Q1 -- -- -$1.32 -- --
03/12/2020 Q4 -- -- -$1.21 -- --
11/11/2019 Q3 -- -- -$1.32 -- --
08/08/2019 Q2 -- -- -$1.98 -- --
05/09/2019 Q1 -- -- -$1.65 -- --
03/14/2019 Q4 -- -- -$1.87 -- --
11/09/2018 Q3 -- -- -$1.10 -- --
08/14/2018 Q2 -- -- -$2.64 -- --
05/10/2018 Q1 -- -- -$1.21 -- --
03/15/2018 Q4 -- -- -$1.98 -- --
11/08/2017 Q3 -- -- -$1.10 -- --
08/09/2017 Q2 -- -- -$1.54 -- --
05/09/2017 Q1 -- -- -$0.99 -- --
03/15/2017 Q4 -- -- -$1.10 -- --
11/07/2016 Q3 -- -- -$0.99 -- --
08/08/2016 Q2 -- -- -$1.21 -- --
05/10/2016 Q1 -- -- -$1.10 -- --
02/29/2016 Q4 -- -- -$1.32 -- --
11/09/2015 Q3 -- -- -$0.55 -- --
08/04/2015 Q2 -- -- -$0.55 -- --
05/07/2015 Q1 -- -- -$0.77 -- --
02/26/2015 Q4 -- -- -$1.65 -- --

Rockwell Medical Earnings Questions

  • How Much did Rockwell Medical Generate in Revenue Last Quarter?

    Rockwell Medical reported $28.3M worth of top line sales in its most recent quarter.

  • Did Rockwell Medical Beat Earnings Last Quarter?

    Rockwell Medical announced earnings per share of $0.04 which represents a beat of analyst forecast a -$0.01 per share.

  • Is Rockwell Medical Profitable?

    Rockwell Medical reported $6.2M that represents $0.19 per share over the last quarter.

  • What is the Analyst Consensus for Rockwell Medical EPS Next Year?

    Rockwell Medical's earnings are forecast to decrease from -$0.37 per share to -- per share next year representing a decrease of -73.28%.

  • When is Rockwell Medical's Earnings Date?

    Rockwell Medical's next earnings date is March 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock